Spiramine A is primarily used in research settings for its bioactive properties, particularly in studies related to cellular signaling and mitochondrial function. It has shown potential as a modulator of membrane-associated processes, making it valuable in investigating apoptosis and autophagy pathways. Due to its ability to influence energy metabolism in eukaryotic cells, Spiramine A is employed as a tool compound in neurodegenerative disease research, especially in models involving oxidative stress. It is also explored for its antiproliferative effects in certain cancer cell lines, supporting its use in early-stage oncology studies. Its application remains confined to laboratory and preclinical research, with no current use in clinical or industrial processes.